Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in β-thalassemia/hemoglobin E disease

Blood

Volumn 87, Issue 3, 1996, Pages 887-892

  Fucharoen, Suthat ^b   Siritanaratkul, Noppadol ^b   Winichagoon, Pranee ^b   Chowthaworn, Jew ^b   Siriboon, Wipapun ^b   Muangsup, Wanna ^b   Chaicharoen, Suchet ^b   Poolsup, Nalinee ^b   Chindavijak, Busaba ^b   Pootrakul, Pensri ^b   Piankijagum, Anong ^b   Schechter, Alan N ^b   Rodgers, Griffin P ^a  

^a Fluorescence Imaging Facility   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; GAMMA GLOBIN; HEMOGLOBIN E; HEMOGLOBIN F; HYDROXYUREA;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DOSE RESPONSE; ERYTHROPOIESIS; FEMALE; HEMOGLOBIN DETERMINATION; HEMOGLOBINOPATHY; HUMAN; LEUKOCYTE COUNT; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETICULOCYTE COUNT; SEPSIS; SPLENECTOMY; STREPTOCOCCUS PNEUMONIA;

EID: 13344259315     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.3.887.bloodjournal873887     Document Type: Article

References (31)

1. Wasi P, Na-Nakron S, Pootrakul S, Sookanck M, Disthasongehan P, Pornpatkul M, Panich V: Alpha-and beta-thalassemia in Thailand. Ann N Y Acad Sc 165:60, 1969
2. Fucharoen S, Winichagoon P: Hemoglobinopathies in Southeast Asia. Hemoglobin 11:65, 1989
3. Fucharoen S, Winichagoon P, Pootrakul P, Wasi P: Determination for different severity of anemia in thalassemia: Concordance and discordance among sib pairs. Am J Med Genet 19:39, 1984
4. Wasi P, Pootrakul P, Fucharoen S, Winichagoon P, Wilairat P, Promboon A: Thalassemia in Southeast Asia: Determinants of different degrees of severity of anemia in Thalassemia. Ann N Y Acad Sci 445:119, 1985
5. Fucharoen S, Winichagoon P, Pootrakul P, Piankijagum A, Wasi P: Variable severity of Southeast Asian β-thalassemia/Hb E disease. Birth Defects 23A:41, 1988
6. Winichagoon P, Fucharoen S, Weatherall DJ, Wasi P: Concomitant inheritance of α-thalassemia in β-thalassemia/Hb E. Am J Hematol 20:217, 1985
7. Winichagoon P, Thonglairoam V, Fucharoen S, Wilairat P, Fukumaki Y, Wasi P: Severity differences in β-thalassemia/haemoglobin E syndromes: Implication of genetic factors. Br J Haematol 83:633, 1993
8. Thein SL, Wainscoat JS, Sampietro M, Old JM, Capellini D, Fiorelli G, Modell B, Weatherall DJ: Association of thalassemia intermedia with beta-globin gene haplotype. Br J Haematol 65:367, 1987
9. Perrine RP, Pembrey ME, John P, Perrine S, Shoup F: Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects. Ann Intern Med 88:1, 1978
10. Ley TJ: The pharmacology of hemoglobin switching of mice and men. Blood 77:1146, 1991
11. Stamatoyannopoulos JA, Neinhuis AW: Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies. Annu Rev Med 43:497, 1992
12. Rodgers GP: Pharmacological modulation of fetal hemoglobin, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, p 829
13. Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW: Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea N Engl J Med 332:1037, 1990
14. Charache S, Dover GJ, Moore RD, Ecken S, Ballas SK, Koshy M, Milner PF, Orringer EP, Phillips G Jr, Platt OS: Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia. Blood 79:2555, 1992
15. Voskandou E, Kalotychou V, Loukopoulos D: Clinical and laboratory effects of long-term administration of hydroxyurea to patients with sickle cell/β-thalassemia. Br J Haematol 89:479, 1995
16. Marengo-Row AJ: Rapid electrophoresis and quantitation of hemoglobins on cellulose acetate. J Clin Pathol 18:790, 1965
17. Aγ ratio in fetal hemoglobin and to studies of globin synthesis. Br J Haematol 44:527, 1980
18. Weatherall DJ, Clegg JB: Structure, function, genetics and biosynthesis of hemoglobin, in Weatherall DJ, Clegg JB (eds): The Thalassemia Syndromes. Oxford, UK, Blackwell Scientific, 1981, p 19
19. Winichagoon P, Higgs DR, Goodboum SEY, Clegg JB, Weatherall DJ: The molecular basis of α-thalassemia in Thailand. EMBO J 3:181, 1984
20. Remington RD, Schork MD: Statistics With Applications to the Biological and Health Sciences. Englewood Cliffs, NJ, Prentice-Hall, 1970
21. Sanguantsermsri T: Resistance of hemoglobin Bart's to acid elution. J Med Assoc Thai 61:62, 1978
22. Fucharoen S, Piankijagum A, Wasi P: Deaths in β-thalassemia/Hb E patients secondary to infections. Birth Defects 23:495, 1988
23. Hajjar FM, Pearson HA: Pharmacologic treatment of thalassemia intermedia with hydroxyurea. J Pediatr 125:490, 1994
24. Bachir D, Galacteros F: Potential alternatives to erythrocyte transfusion in hemoglobinopathies: Hydroxyurea, erythropoietin, butyrate derivatives, blood substitutes. Transfus Clin Biol 1:35, 1994
25. Huang SZ, Zeng YT, Lu ZH, Ren ZR, Schechter AN, Rodgers GP: Hydroxyurea therapy in beta-thalassemia intermedia: Improvement in hematological parameters due to enhanced beta-globin synthesis. Br J Haematol 90:557, 1995
26. Dover GJ, Boyer SH, Charache S, Heintzelman K: Individual variation in the production and survival of F-cells in sickle cell disease. N Engl J Med 299:1428, 1978
27. Goldstein AR, Anderson MJ, Serjeant GR: Parvovirus associated aplastic crisis in homozygous sickle cell disease. Arch Dis Child 62:585, 1987
28. Perrine SP, Ginder GD, Faller DV, et al: A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med 328:81, 1993
29. Collins AF, Pearson HA, Giardina P, McDonagh KT, Brusilow SW, Dover GJ: Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: A clinical trial. Blood 85:43, 1995
30. Fibach E, Prasanna P, Rodgers GP, Samid D: Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia. Blood 82:2203, 1993
31. Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW: Erythropoietin augments the fetal hemoglobin response to hydroxyurea in sickle cell patients. N Engl J Med 328:75, 1993